BAY 1817080
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY 1817080, covering 2023-01-26 to 2023-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients [Phase 1, Phase 2]